您的位置: 首页 > 农业专利 > 详情页

用於治療心臟衰竭之合成環狀多肽
专利权人:
NOVARTIS AG
发明人:
ZECRI, FREDERIC,GROSCHE, PHILIPP,YASOSHIMA, KAYO,ZHAO, HONGJUAN,YUAN, JUN,USERA, AIMEE RICHARDSON,LOU, CHANG-GANG,KANTER, AARON,GUIMARAES, CARLA,BRUCE, ALEXANDRA MARSHALL
申请号:
TW103124998
公开号:
TW201536814A
申请日:
2014.07.21
申请国别(地区):
TW
年份:
2015
代理人:
摘要:
The invention provides a cyclic polypeptide of Formula I': X1-R-X3-X4-L-S-X7-X8-X9-X10-X11-X12-X13 I or an amide, an ester or a salt thereof, or a bioconjugate thereof, wherein X1, X3, X4, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides of the invention or bioconjugates thereof, and their therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.本發明提供一種式I'之環狀多肽:X1-R-X3-X4-L-S-X7-X8-X9-X10-X11-X12-X13 I或其醯胺、酯或鹽,或其生物結合物,其中X1、X3、X4、X7、X8、X9、X10、X11、X12及X13係如本文所定義。該多肽為APJ受體之促效劑。本發明亦關於一種用於製造本發明之多肽或其生物結合物之方法,及其治療性用途,諸如治療或預防急性失代償心臟衰竭(ADHF)、慢性心臟衰竭、肺高血壓、心房纖維性顫動、布魯加達症候群(Brugada syndrome)、心室性心搏過速、動脈粥樣硬化、高血壓、再狹窄、缺血性心血管疾病、心肌病、心臟纖維化、心律不整、水滯留、糖尿病(包括妊娠期糖尿病)、肥胖症、周邊動脈疾病、腦血管意外、短暫性缺血性發作、外傷性腦損傷、肌萎縮性側索硬化、燒傷(包括曬傷)及子癇前症。本發明另外提供藥理學活性劑之組合與醫藥組合物。
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充